Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Key considerations in the preclinical development of biosimilars.
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM. Bui LA, et al. Among authors: kirchhoff cf. Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23. Drug Discov Today. 2015. PMID: 25912284 Review.
Development of biosimilars.
Al-Sabbagh A, Olech E, McClellan JE, Kirchhoff CF. Al-Sabbagh A, et al. Among authors: kirchhoff cf. Semin Arthritis Rheum. 2016 Apr;45(5 Suppl):S11-8. doi: 10.1016/j.semarthrit.2016.01.002. Epub 2016 Jan 21. Semin Arthritis Rheum. 2016. PMID: 26947440 Review.
The 'totality-of-the-evidence' approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference product.
McClellan JE, Conlon HD, Bolt MW, Kalfayan V, Palaparthy R, Rehman MI, Kirchhoff CF. McClellan JE, et al. Among authors: kirchhoff cf. Therap Adv Gastroenterol. 2019 Jun 13;12:1756284819852535. doi: 10.1177/1756284819852535. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31223341 Free PMC article. Review.
14 results